CAS: 1229575-09-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Lenzilumab REF: TM-T76751CAS: 1229575-09-0 | 95% - 95% | 402.00 €~2,908.00 € | Tue 07 Jan 25 |
 | Lenzilumab REF: 3D-CLA1367CAS: 1229575-09-0 | - - - | To inquire | Wed 15 Jan 25 |
Lenzilumab
CAS:1229575-09-0
Lenzilumab (KB 003) is a humanized GM-CSF neutralizing antibody for the study of COVID-19.
Purity:
95% - 95%
Color and Shape:
Liquid
Ref: TM-T76751
| 1mg | 402.00 € | ||
| 5mg | 1,175.00 € | ||
| 10mg | 1,711.00 € | ||
| 25mg | 2,908.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 3D-CLA1367
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
